Sham HD-tDCS
Sham HD-tDCS is a medical device with 11 clinical trials. Currently 2 active trials ongoing. Historical success rate of 71.4%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
2
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury
HD-tDCS for Adolescent Bipolar Depression Targeting S1
Recovering Arm Function in Chronic Post-stroke Patients Using Combined HD-tDCS and Virtual Reality Therapy
Targeting Repetitive Behaviors in Autism Spectrum Disorder Via Transcranial Direct Current Stimulation
HD-Tdcs and Pharmacological Intervention For Delirium In Critical Patients With COVID-19
Clinical Trials (11)
Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Injury
HD-tDCS for Adolescent Bipolar Depression Targeting S1
Recovering Arm Function in Chronic Post-stroke Patients Using Combined HD-tDCS and Virtual Reality Therapy
Targeting Repetitive Behaviors in Autism Spectrum Disorder Via Transcranial Direct Current Stimulation
HD-Tdcs and Pharmacological Intervention For Delirium In Critical Patients With COVID-19
Investigation and Modulation of the Mu-opioid Mechanisms in TMD (in Vivo)
Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS
High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms of Schizophrenia
Modulation of an Experimental Prolonged Pain Model Using High Definition Transcranial Direct Current Stimulation
Investigating the Neural Correlates in Memory Retrieval After HD-tDCS
Patient Centered-Rehabilitation ver111090.1
All 11 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 11